Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Schuler

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Cancer Immunology, Immunotherapy : CII|September 5, 2007
Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodesJan Dörrie, Niels Schaft, Ina Müller, et al.
Immunity|May 18, 2010
Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cellsKathrin Schumann, Tim Lämmermann, Markus Bruckner, et al.
The Journal of Investigative Dermatology|June 4, 2004
BP230- and BP180-specific auto-antibodies in bullous pemphigoidSybille Thoma-Uszynski, Wolfgang Uter, Susanne Schwietzke, et al.
Anticancer Research|September 6, 2017
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic CellsUgur Uslu, Stefan Schliep, Klaus Schliep, et al.
The Journal of Experimental Medicine|May 22, 2002
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cellsBeatrice Schuler-Thurner, Erwin S Schultz, Thomas G Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skinGudrun Ratzinger, Patrizia Stoitzner, Susanne Ebner, et al.
Journal of Immunology Research|January 30, 2016
Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic CellsStefanie Hoyer, Kerstin F Gerer, Isabell A Pfeiffer, et al.
Cancer Immunology, Immunotherapy : CII|October 31, 2015
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backboneChristian Krug, Katrin Birkholz, Alexander Paulus, et al.
Therapeutic Advances in Medical Oncology|July 19, 2017
Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccinationKerstin F Gerer, Michael Erdmann, Sine R Hadrup, et al.
Oncoimmunology|July 30, 2016
Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesisKatharina Lankes, Gheorghe Hundorfean, Thomas Harrer, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Cancer Immunology, Immunotherapy : CII|September 5, 2007
Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodesJan Dörrie, Niels Schaft, Ina Müller, et al.
Immunity|May 18, 2010
Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cellsKathrin Schumann, Tim Lämmermann, Markus Bruckner, et al.
The Journal of Investigative Dermatology|June 4, 2004
BP230- and BP180-specific auto-antibodies in bullous pemphigoidSybille Thoma-Uszynski, Wolfgang Uter, Susanne Schwietzke, et al.
Anticancer Research|September 6, 2017
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic CellsUgur Uslu, Stefan Schliep, Klaus Schliep, et al.
The Journal of Experimental Medicine|May 22, 2002
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cellsBeatrice Schuler-Thurner, Erwin S Schultz, Thomas G Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skinGudrun Ratzinger, Patrizia Stoitzner, Susanne Ebner, et al.
Journal of Immunology Research|January 30, 2016
Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic CellsStefanie Hoyer, Kerstin F Gerer, Isabell A Pfeiffer, et al.
Cancer Immunology, Immunotherapy : CII|October 31, 2015
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backboneChristian Krug, Katrin Birkholz, Alexander Paulus, et al.
Therapeutic Advances in Medical Oncology|July 19, 2017
Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccinationKerstin F Gerer, Michael Erdmann, Sine R Hadrup, et al.
Oncoimmunology|July 30, 2016
Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesisKatharina Lankes, Gheorghe Hundorfean, Thomas Harrer, et al.
Pageof 19